Symrise Divests AmeriTerpenes to Mutares in Portfolio Shift

Symrise AG has entered into a definitive agreement to divest AmeriTerpenes LLC, its terpene ingredients business, to international private equity investor Mutares SE & Co. KGaA. The transaction reflects Symrise’s ongoing portfolio optimization strategy under its ONE Symrise framework, allowing the company to concentrate resources and management attention on its core growth platforms.

AmeriTerpenes is a major producer of renewable terpene ingredients, supplying customers in the fragrance, flavor, and industrial sectors. The business operates manufacturing facilities in Jacksonville, Florida, and Colonels Island, Georgia, serving customers that increasingly demand renewable, reliable, and high-performance ingredients for a wide range of formulations.

The divestment follows the completion of an operational carve-out over recent months, positioning AmeriTerpenes to operate independently under Mutares’ ownership. The new ownership is expected to provide the business with a dedicated focus on operational development and expansion while preserving existing customer and supplier relationships.

For Symrise, the transaction represents another step in reshaping its portfolio and strengthening its focus on sustainable profitable growth, operational efficiency, and disciplined capital allocation. Symrise CEO Dr. Jean-Yves Parisot described AmeriTerpenes as a strong business supported by experienced employees, established customer relationships, and differentiated manufacturing capabilities. He added that Mutares’ experience with corporate carve-outs makes it a suitable owner for the next stage of the company’s development.

For Mutares, AmeriTerpenes becomes a new platform investment within its Chemicals & Materials segment and expands its presence in the strategically important U.S. market. Mutares CIO Johannes Laumann said the acquisition fits the investment firm’s strategy of pursuing corporate carve-outs and building platforms with growth potential.

The companies also plan to maintain their commercial relationship after the transaction closes. Supply agreements will provide Symrise with continued access to renewable terpene-based raw materials, while AmeriTerpenes will retain a longstanding industrial relationship with its former parent.

The signing and closing occurred simultaneously, although the financial terms remain undisclosed. Symrise expects the divestment to generate a non-cash disposal loss in the mid-double-digit million-euro range, which will be recognized in its 2026 annual financial statements.

Overall, the transaction gives AmeriTerpenes a more focused ownership structure while enabling Symrise to streamline its portfolio and prioritize businesses aligned with its long-term growth strategy.

Product & Chemical Commodity Price Impact

The divestment is likely to have a limited immediate impact on terpene prices, as production capacity and customer supply are expected to remain operational after the ownership transition. Continued supply agreements between Symrise and AmeriTerpenes should reduce the risk of disruptions in renewable terpene-based raw materials. Over the medium term, Mutares could invest in capacity, efficiency, and product development, potentially improving supply availability and limiting upward price pressure. For Chemanalyst-tracked commodities, terpenes and related fragrance and flavor intermediates could remain broadly stable initially. However, stronger downstream demand or future capacity changes at AmeriTerpenes could influence regional pricing and market balances.